Skip to main content
Top
Published in: Irish Journal of Medical Science (1971 -) 2/2018

01-05-2018 | Original Article

Geographic distribution and incidence of Lyme borreliosis in the west of Ireland

Authors: A. Vellinga, H. Kilkelly, J. Cullinan, B. Hanahoe, M. Cormican

Published in: Irish Journal of Medical Science (1971 -) | Issue 2/2018

Login to get access

Abstract

Background

Lyme borreliosis is caused by Borrelia burgdorferi and is the most common tick-transmitted infection in temperate regions. Infection often presents with erythema migrans and/or other clinical features in early infection.

Methods

Blood samples are submitted for testing for antibodies to Borrelia burgdorferi by enzyme immunoassay and positive samples are confirmed by a reference laboratory by IgG and IgM line immune assay. A retrospective extraction of all laboratory requests and results for Lyme borreliosis from 2011 to 2014 was performed. Patient addresses were mapped to local electoral area (LEA).

Results

The total number of requests was 5049 and 242 (5%) were positive over 5 years. The number of positive and tested samples were 40/748, 45/905, 41/947, 73/1126 and 43/1323 from 2011 to 2014. Even though the number of requests increased over the years, there was no significant increase in the number of positives.
Incidences per 100,000 population for requests and positives were calculated at LEA level and showed considerable variation. The highest incidence was shown in one LEA (Connemara) with nearly 500 requests and 43 positives per 100,000 population per year.

Conclusions

Increased awareness may explain the increase in requests. There is no indication of an increase in incidence. As many GPs treat suspected Lyme borreliosis empirically without testing and as antibody may be undetectable early in the course of illness, the true incidence of infection is likely to exceed the number of laboratory-confirmed cases.
Literature
3.
go back to reference Berger KA, Ginsberg HS, Gonzalez L, Mather TN (2014) Relative humidity and activity patterns of Ixodes scapularis (Acari: Ixodidae). J Med Entomol 51(4):769–776CrossRefPubMed Berger KA, Ginsberg HS, Gonzalez L, Mather TN (2014) Relative humidity and activity patterns of Ixodes scapularis (Acari: Ixodidae). J Med Entomol 51(4):769–776CrossRefPubMed
4.
go back to reference Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R (2011) Lyme borreliosis in Europe. Euro Surveill 16(27) Rizzoli A, Hauffe H, Carpi G, Vourc HG, Neteler M, Rosa R (2011) Lyme borreliosis in Europe. Euro Surveill 16(27)
7.
go back to reference Steere AC, Dhar A, Hernandez J, Fischer PA, Sikand VK, Schoen RT, Nowakowski J, McHugh G, Persing DH (2003) Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med 114(1):58–62CrossRefPubMed Steere AC, Dhar A, Hernandez J, Fischer PA, Sikand VK, Schoen RT, Nowakowski J, McHugh G, Persing DH (2003) Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease. Am J Med 114(1):58–62CrossRefPubMed
8.
go back to reference Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43(9):1089–1134. https://doi.org/10.1086/508667 CrossRefPubMed Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS, Krause PJ, Bakken JS, Strle F, Stanek G, Bockenstedt L, Fish D, Dumler JS, Nadelman RB (2006) The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43(9):1089–1134. https://​doi.​org/​10.​1086/​508667 CrossRefPubMed
9.
go back to reference Smith R, Takkinen J (2006) Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro Surveill 11(6):E060622 060621 Smith R, Takkinen J (2006) Lyme borreliosis: Europe-wide coordinated surveillance and action needed? Euro Surveill 11(6):E060622 060621
11.
go back to reference McKeown P (2016) Lyme disease. Epi-Insight 17(5) McKeown P (2016) Lyme disease. Epi-Insight 17(5)
15.
go back to reference Robertson JN, Gray JS, MacDonald S, Johnson H (1998) Seroprevalence of Borrelia burgdorferi sensu lato infection in blood donors and park rangers in relation to local habitat. Zentralbl Bakteriol 288(2):293–301CrossRefPubMed Robertson JN, Gray JS, MacDonald S, Johnson H (1998) Seroprevalence of Borrelia burgdorferi sensu lato infection in blood donors and park rangers in relation to local habitat. Zentralbl Bakteriol 288(2):293–301CrossRefPubMed
16.
go back to reference Smith HV, Gray JS, McKenzie G (1991) A Lyme borreliosis human serosurvey of asymptomatic adults in Ireland. Zentralbl Bakteriol 275(3):382–389CrossRefPubMed Smith HV, Gray JS, McKenzie G (1991) A Lyme borreliosis human serosurvey of asymptomatic adults in Ireland. Zentralbl Bakteriol 275(3):382–389CrossRefPubMed
17.
go back to reference de Barrra E, Muldoon E (2010) West of Ireland Lyme Borreliosis Mapping Project. Paper presented at the Infectious Disease Society Ireland (IDSA) de Barrra E, Muldoon E (2010) West of Ireland Lyme Borreliosis Mapping Project. Paper presented at the Infectious Disease Society Ireland (IDSA)
19.
go back to reference Central Statistics Office C (2011) Census of the Irish Population, 2011 Central Statistics Office C (2011) Census of the Irish Population, 2011
Metadata
Title
Geographic distribution and incidence of Lyme borreliosis in the west of Ireland
Authors
A. Vellinga
H. Kilkelly
J. Cullinan
B. Hanahoe
M. Cormican
Publication date
01-05-2018
Publisher
Springer London
Published in
Irish Journal of Medical Science (1971 -) / Issue 2/2018
Print ISSN: 0021-1265
Electronic ISSN: 1863-4362
DOI
https://doi.org/10.1007/s11845-017-1700-2

Other articles of this Issue 2/2018

Irish Journal of Medical Science (1971 -) 2/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.